SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-21-036474
Filing Date
2021-07-13
Accepted
2021-07-13 16:57:32
Documents
3
Effectiveness Date
2021-07-13

Document Format Files

Seq Description Document Type Size
1 S-8 kalv-s8.htm S-8 111989
2 EX-5.1 kalv-ex51_7.htm EX-5.1 14421
3 EX-23.1 kalv-ex231_8.htm EX-23.1 2421
  Complete submission text file 0001564590-21-036474.txt   130162
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-8 | Act: 33 | File No.: 333-257871 | Film No.: 211088483
SIC: 2834 Pharmaceutical Preparations